Astrazeneca reported $9.74B in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Astrazeneca AZN:US USD 9.74B 495M
AstraZeneca AZN:LN USD 9.74B 495M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Canopy Growth Corp WEED:CN CAD 277.53M 1.69B
Catalent CTLT:US USD 962M 105M
Corcept Therapeutics CORT:US USD 69.79M 2.16M
Drreddys Laboratories RDY:US INR 51.28B 4.35B
Eli Lilly And LLY:US USD 5.47B 200.3M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Genmab GEN:DC DKK 2.16B 241M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Horizon Pharma HZNP:US USD 764.75M 23.1M
JAZZ PHA JAZZ:US USD 915.89M 68.56M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Merk MRK:US USD 10.32B 624M
Novartis NOVN:VX USD 10.67B 183M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 19.12B 5.9B
Prestige Brands PBH:US USD 188.34M 16.55M
Roche Holding ROG:VX 20.75B 3.26B
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
Valeant Pharmaceuticals VRX:CN USD 1.23B 461M
Zoetis ZTS:US USD 1.34B 47M